| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/28/1991 | WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/28/1991 | CA2028538A1 4-substituted isoquinolone derivatives, their production and use |
| 04/25/1991 | WO1991006296A1 Bafilomycine macrolides for treatment of bone affecting diseases |
| 04/25/1991 | CA2071914A1 Bafilomycine macrolides for treatment of bone affecting diseases |
| 04/24/1991 | EP0424214A1 5-[2-[[2-Amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5H)-benzothiazepine-4-one derivatives, their preparation and their use in therapy |
| 04/24/1991 | EP0424195A1 Imidazoles |
| 04/24/1991 | EP0424193A2 Use of actinonin for the manufacture of a medicament for angiogenesis inhibition |
| 04/24/1991 | EP0423842A2 Steroids and therapeutic compositions containing same |
| 04/24/1991 | EP0423419A1 Inhibitive agent against activity of alpha-amylase |
| 04/24/1991 | EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
| 04/24/1991 | EP0423318A1 Therapeutic cholesterol gallstone dissolution method. |
| 04/24/1991 | CN1050879A Novel alpha-glucosidase inhibitors |
| 04/23/1991 | US5010091 2,4-dihalogeno-6-pyridylethanolphenylisopropylamines for shifting the protein-fat ratio of animals in favor of protein |
| 04/23/1991 | US5010072 Lactamimides as calcium antagonists |
| 04/23/1991 | US5010056 Pharmaceutical composition for intranasal administration, comprising GH-releasing hormone, a cholinergic agonist and optionally a bile salt |
| 04/23/1991 | CA1283422C Hydroxyvitamin d _compounds and process for preparing same |
| 04/21/1991 | CA2013562A1 Crystalline 2-0- -d-glucopyranosyl-l-ascorbic acid, and its preparation and uses |
| 04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 04/18/1991 | WO1991004735A1 Compositions and methods for weight reduction |
| 04/18/1991 | CA2027738A1 5-{2-[(2-amino-2-oxoethyl) (methyl)amino]ethyl}-2,3-dihydro-3-hydroxy-2-(4-methoxyphen yl)-1,5(5h)-benzothiazepin-4-one derivatives, their preparation and their application in therapy |
| 04/17/1991 | EP0422975A1 Alpha-glucosidase inhibitors |
| 04/17/1991 | EP0422895A1 Chemical compounds |
| 04/17/1991 | EP0422818A1 New polyether antibiotic |
| 04/17/1991 | EP0422666A2 6-Substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/17/1991 | EP0422490A2 Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels |
| 04/17/1991 | EP0422307A1 Novel alpha-glucosidase inhibitors |
| 04/17/1991 | EP0422102A1 5-OXA, 5-THIA, 5-AZA HMG-CoA REDUCTASE INHIBITORS |
| 04/17/1991 | EP0422100A1 11-g(b)-SUBSTITUTED PROGESTERONE ANALOGS. |
| 04/17/1991 | CN1050715A Quinoline derivatives, their production and use |
| 04/16/1991 | US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 04/16/1991 | US5008272 Antagonists; useful in treatment of psychotic disorders, central nervous system disorder; antidepressant |
| 04/16/1991 | US5008119 Increasing metallothioneim level in host |
| 04/16/1991 | CA1283122C Phenyl ethers |
| 04/16/1991 | CA1283119C Hydroxyacetic acid derivatives for the treatment of diabetic complications |
| 04/14/1991 | CA2027325A1 6-substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/13/1991 | CA2025314A1 Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels |
| 04/11/1991 | CA2027179A1 Chemical compounds |
| 04/11/1991 | CA2026716A1 Polyether antibiotic |
| 04/10/1991 | EP0421561A2 24-D-homo-vitamin D-derivatives, a process for their production, pharmaceutical compositions containing them and their use as medicines |
| 04/10/1991 | EP0421456A2 Quinoline derivatives, their production and use |
| 04/10/1991 | EP0421365A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
| 04/10/1991 | EP0420930A1 Method of synthesis and novel compounds for pharmaceutical uses |
| 04/09/1991 | US5006655 Process for the preparation of tetrahydrofolates |
| 04/09/1991 | US5006648 Process for preparing partial polyol fatty acid esters |
| 04/09/1991 | US5006530 Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases |
| 04/09/1991 | US5006518 Hormone inhibitors for inducing abortions; nontoxic |
| 04/09/1991 | US5006360 Liquid and solid polyol fatty acid polyesters with network of polysaccharide fibrils, microfibrils |
| 04/09/1991 | CA1282786C Glucose tolerance factor and method of making same |
| 04/09/1991 | CA1282702C Regimen for treating osteoporosis |
| 04/05/1991 | CA2026713A1 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 04/04/1991 | WO1991004258A1 Inositol derivative and production thereof |
| 04/04/1991 | WO1991004027A1 New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| 04/04/1991 | WO1991003948A1 Liquid nutrient composition |
| 04/03/1991 | WO1991004751A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | WO1991004737A1 Osteogenesis promoter |
| 04/03/1991 | EP0420716A2 Benzodiazepines, process and intermediates for their preparation and their therapeutic use |
| 04/03/1991 | EP0420266A2 Chromene or thiochromene derivatives, process for preparing the same, intermediate therefor, pharmaceutical compositions containing said derivatives and the use of said derivatives |
| 04/03/1991 | EP0420232A2 Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions |
| 04/03/1991 | EP0420116A2 Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| 04/03/1991 | EP0419885A1 Fluid, stable beverage and tube-feed nourishment containing guar flour |
| 04/03/1991 | EP0419856A2 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
| 04/03/1991 | CN1050380A Substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| 04/03/1991 | CN1050376A Acylcoenzyme a: cholesterol acyltransferase inhibitors |
| 04/03/1991 | CA2067353A1 Inhibitor of absorption of digestion product of food and drink |
| 04/02/1991 | CA1282411C 1,4,5,6,7,8-hexahydroquinoline compounds |
| 04/02/1991 | CA1282409C2 Pyrazolo[4,3-d]pyrimidine derivative, process for its production, antihyperlipidemic agent containing it, its intermediate and process for the production of the intermediate |
| 03/30/1991 | CA2026389A1 Chromene or thiochromene derivatives, process for preparing the same and intermediate therefor |
| 03/29/1991 | CA2026123A1 Benzodiazepines, their process of production, intermediate products and applications in therapeutic practice |
| 03/29/1991 | CA2023857A1 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
| 03/28/1991 | CA2026274A1 Imidazoles |
| 03/27/1991 | EP0419394A1 Non-digoxin-like Na+,K+-ATPase inhibitory factor |
| 03/27/1991 | EP0419131A2 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 03/27/1991 | EP0419035A1 Thiazolidine dione derivatives |
| 03/27/1991 | EP0418814A2 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method for preparing the same |
| 03/27/1991 | EP0418797A2 Pyrimidin-4,6-dicarboxilic acid diamides, process for their preparation also medicine based on those compounds |
| 03/27/1991 | EP0418648A1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors |
| 03/27/1991 | CN1050183A New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholestrol acyl transferase |
| 03/26/1991 | US5003098 Administering a Myo-Inositol Triphosphate |
| 03/26/1991 | US5003080 Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
| 03/26/1991 | US5002968 Organogermanium compound, calcium metabolism |
| 03/26/1991 | US5002953 Novel compounds |
| 03/26/1991 | US5002937 Diphosphonic acid compounds and use for calcium metabolism disorders |
| 03/26/1991 | CA1282062C Quaternary ammonium salts of natural polysaccharides possessing hypocholesterolemic activity |
| 03/22/1991 | CA2025799A1 Pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation and the use thereof, and pharmaceuticals based on these compounds |
| 03/21/1991 | WO1991003240A1 Methods of preventing and reducing the size of striae distensae lesions |
| 03/21/1991 | WO1991003233A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
| 03/21/1991 | DE3930130A1 Neue amidingruppen-haltige diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New amidine-containing diphosphonic acid derivatives, process for their production and pharmaceutical compositions containing them |
| 03/20/1991 | EP0418071A2 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase |
| 03/20/1991 | EP0417725A2 Bile-acid derivatives, a process for their production and their use as medicines |
| 03/20/1991 | EP0417604A2 Process for preparing riboflavin-5'-phosphate and its sodium salt |
| 03/20/1991 | EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus |
| 03/20/1991 | EP0417238A1 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same. |
| 03/20/1991 | EP0417217A1 Peptides with sulphate ester groups |
| 03/20/1991 | EP0417209A1 Compositions and methods for administering therapeutically active compounds |
| 03/20/1991 | EP0417143A1 Cyclic lactams for cholesterol and atherosclerosis control |
| 03/20/1991 | CN1050022A Process for preparing dehydrocycloclausenamide derivatives |
| 03/20/1991 | CA2023813A1 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4 - tetrahydroquinolinyl group having retinoid-like activity |
| 03/19/1991 | US5001282 Method of treating diabetes mellitus with bisphenol derivatives |
| 03/19/1991 | US5001241 3-KETO HMG-CoA reductase inhibitors |
| 03/19/1991 | US5001222 Des-17-histidine-calcitonin |